Strata Critical Medical Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Strata Critical Medical stock has a consensus rating of "Strong Buy" and an average price target of $9.25. The average 1-year stock price forecast is 59.76% higher than the current stock price, while the lowest is $8.00 (+38.17%) and the highest is $11.5 (+98.62%).

Price Target: $9.25 (+59.76%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$8.00	$9.25	$8.75	$11.5
Change	+38.17%	+59.76%	+51.12%	+98.62%

* Price targets were last updated on May 7, 2026.

Analyst Ratings

The average analyst rating for Strata Critical Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	1	2	4	4	4	4
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	2	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jon Hickman Ladenburg Thalmann & Co.	Ladenburg Thalmann & Co.	Buy Reiterates $12	Buy	Reiterates	$12	+98.62%	May 7, 2026
Ben Haynor Lake Street	Lake Street	Buy Reiterates $8	Buy	Reiterates	$8	+38.17%	May 6, 2026
William Bonello Craig-Hallum	Craig-Hallum	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 6, 2026
Yuan Zhi B. Riley Securities	B. Riley Securities	Buy Initiates $8	Buy	Initiates	$8	+38.17%	Mar 25, 2026

Financial Forecast

Revenue This Year

274.25M

from 197.14M

39.11%

from 197.14M

Revenue Next Year

303.63M

from 274.25M

10.71%

from 274.25M

EPS This Year

-0.14

from -

EPS Next Year

-0.03

from -0.14

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	67.16M	146.12M	225.18M	146.82M	197.14M	274.25M
Revenue Growth	32.92%	117.58%	54.11%	-34.80%	34.28%	39.11%
Gross Profit	12.85M	22.28M	42.12M	29.59M	41.13M	59.24M
Gross Margin	19.14%	15.24%	18.71%	20.15%	20.86%	21.60%
Operating Income	-32.26M	-50.50M	-44.68M	-21.11M	-12.61M	-8.77M
Net Income	-36.92M	-27.26M	-56.08M	-27.31M	41.35M	-5.76M
EPS	-	-	-	-	-	-0.14
Free Cash Flow	-	-18.34M	-11.67M	-28.89M	-26.98M	19.00M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	280.0M
Avg	274.3M
Low	268.1M

Revenue Growth

Revenue Growth	2026	2027	2028
High	42.0%
Avg	39.1%
Low	36.0%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.14
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-